Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Blueprint Medicines Corp | PRESIDENT, R & D | Common Stock | 69.1K | $6.17M | $89.32 | Oct 3, 2024 | Direct |
Aprea Therapeutics, Inc. | Director | Common Stock | 4.61K | $17K | $3.68 | Jun 30, 2021 | Direct |
Blueprint Medicines Corp | PRESIDENT, R & D | Stock Option (Right to Buy) | 30K | Mar 1, 2024 | Direct | ||
Vor Biopharma Inc. | Director | Stock Option (Right to Buy) | 30K | May 23, 2024 | Direct | ||
Aprea Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 22.8K | Jun 30, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BPMC | Blueprint Medicines Corp | Oct 3, 2024 | 1 | -$324K | 4 | Oct 4, 2024 | PRESIDENT, R & D |
VOR | Vor Biopharma Inc. | May 23, 2024 | 1 | $0 | 4 | May 28, 2024 | Director |
VOR | Vor Biopharma Inc. | Apr 30, 2024 | 1 | $0 | 4 | May 2, 2024 | Director |
VOR | Vor Biopharma Inc. | Apr 30, 2024 | 0 | $0 | 3 | May 2, 2024 | Director |
BPMC | Blueprint Medicines Corp | Mar 7, 2024 | 1 | -$397K | 4 | Mar 11, 2024 | PRESIDENT, R & D |
BPMC | Blueprint Medicines Corp | Mar 1, 2024 | 2 | $0 | 4 | Mar 6, 2024 | PRESIDENT, R & D |
BPMC | Blueprint Medicines Corp | Oct 4, 2023 | 1 | -$181K | 4 | Oct 5, 2023 | PRESIDENT, R & D |
BPMC | Blueprint Medicines Corp | Mar 6, 2023 | 2 | -$89K | 4 | Mar 8, 2023 | PRESIDENT, R & D |
BPMC | Blueprint Medicines Corp | Mar 1, 2023 | 2 | $0 | 4 | Mar 3, 2023 | PRESIDENT, R & D |
BPMC | Blueprint Medicines Corp | Oct 4, 2022 | 1 | -$234K | 4 | Oct 5, 2022 | PRESIDENT, R & D |
BPMC | Blueprint Medicines Corp | Mar 7, 2022 | 1 | -$58.8K | 4 | Mar 8, 2022 | PRESIDENT, R & D |
BPMC | Blueprint Medicines Corp | Mar 1, 2022 | 2 | $0 | 4 | Mar 3, 2022 | PRESIDENT, R & D |
BPMC | Blueprint Medicines Corp | Oct 5, 2021 | 1 | -$318K | 4 | Oct 7, 2021 | President, R & D |
APRE | Aprea Therapeutics, Inc. | Jun 30, 2021 | 2 | $0 | 4 | Jul 1, 2021 | Director |